| Basics |
|
Kodiak Sciences Inc
|
| IPO Date: |
October 1, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.05 | 3.77%
|
| Avg Daily Range (30 D): |
$0.94 | 7.14%
|
| Avg Daily Range (90 D): |
$0.58 | 6.14%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.44M |
| Avg Daily Volume (30 D): |
.98M |
| Avg Daily Volume (90 D): |
.65M |
| Trade Size |
| Avg Trade Size (Sh.): |
87 |
| Avg Trade Size (Sh.) (30 D): |
85 |
| Avg Trade Size (Sh.) (90 D): |
88 |
| Institutional Trades |
| Total Inst.Trades: |
1,270 |
| Avg Inst. Trade: |
$2.31M |
| Avg Inst. Trade (30 D): |
$1.35M |
| Avg Inst. Trade (90 D): |
$1.19M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.75M |
| Avg Closing Trade (30 D): |
$1.58M |
| Avg Closing Trade (90 D): |
$1.34M |
| Avg Closing Volume: |
61.34K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-3.63
|
$-1.09
|
$-.84
|
|
Diluted EPS
|
$-3.63
|
$-1.09
|
$-.84
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -190.63M
|
$ -57.46M
|
$ -44.11M
|
|
Operating Income / Loss
|
$ -199.87M
|
$ -59.07M
|
$ -46.18M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -107.07M
|
$ -29.22M
|
$ -29.79M
|
|
PE Ratio
|
|
|
|
|
|
|